medigraphic.com
ISSN 1561-3070 (Electronic)

2020, Number 1

<< Back Next >>

Rev Cub Oftal 2020; 33 (1)

Therapeutic update on pseudophakic bullous keratopathy

Yang T, Mokey CMO, Álvarez RMB

Language: Spanish
References: 32
Page: 1-13
PDF size: 531.22 Kb.


ABSTRACT

Pseudophakic bullous keratopathy or chronic pseudophakic corneal edema in patients undergoing cataract surgery with intraocular lens implantation is a process in which the cornea edematizes and loses optical function, with painful and irritating lacrimation symptoms, red eye, probable inflammation and corneal ulceration due to secondary infection. Sufferers of this multicausal condition are divided into two groups: In one of them structural corneal and ocular damage has been extreme and no visual improvement is expected, whereas in the other visual acuity recovery is still possible. In an attempt to heal this condition various treatments have been used with different rationales and results according to the scientific and technological development of the setting where they were applied. The present update is aimed at describing and adjusting the possible therapies that ophthalmologists may use in their respective fields of activity.


REFERENCES

  1. Bowling B. Kanski's Clinical Ophthalmology - a systematic approach. Elsevier. 2016;6:168- 72.

  2. Jackson TL. Moorfields Manual of Ophthalmology; 2014;157-9.

  3. Fernández MM, Afshari NA. Endotherial Keratoplasty: from DLEK to DMEK. East Afr J Ophthamol. 2010;17(1):5-8.

  4. Domingues E, Gonçalves I, Campos M, Paris F. Bullous keratopathy: etiopathogenesis and treatment. Arq Bras Oftalmol. 2008;71(6):2.

  5. Feizi S. Corneal endothelial cell dysfunction: etiologies and management. Ther Adv Ophthalmol. 2018;7:1-19.

  6. Bowling, Brad. Kanski's Clinical Ophthalmology - A Systematic Approach, Eighth Edition. s.l. : Elsevier, 2016;6:168-172.

  7. TL, Jackson. Moorfields Manual of Ophthalmology. Second edition, 2014; 157-159.

  8. Fernandez MM, Afshari NA. Endotherial Keratoplasty: From DLEK to DMEK. East Afrivan Journal of Ophthamology. 2010;17(1):5-8.

  9. Eliana Domingues GonçalvesI, Mauro Campos, Fabiana Paris. Bullous keratopathy: etiopathogenesis and treatment. Arq. Bras. Oftalmol. 2008; 71(6) supl.0.

  10. Feizi, Sepehr. Corneal endothelial cell dysfunction: etiologies and management. Ther Adv Ophthalmol. 2018;7:1 –19 .

  11. Mokey O, Castellanos M. Indicaciones de las queratoplastias en un centro de referencia nacional. Rev Cubana Oftalmol. 2000;13(1):30-4.

  12. Balasubramaniam P, Chopra V. A comprehensive study of bullous keratapathy. J Evid Based Med Healthc. 2016;3(84):4552-6.

  13. Feinbaum C. A new treatment modality with the Hyper CL soft contact lens. Barcelona: Presentación; 2015.

  14. Guigang Li, Jiao Zheng. Efficacy of anterior stromal puncture surgery with corneal bandage lens for bullous keratopathy. Int J Med Sci. 2019;16(5): 660-4.

  15. Maini R, Sullivan L, Snibson GR, Taylor HR, Loughnan MS. A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy. Brit J Ophthalmol. 2001;85:912-5.

  16. Thomann U, Meier-Gibbons F, Schipper I. Phototherapeutic keratectomy for bullous keratopathy. Brit J Ophthalmol. 1995;79:335-8.

  17. Gundersen T. Surgical treatment of bullous keratopathy. Arch Ophthalmol. 1960;64: 260-7.

  18. Guell JL, Morral M, Gris O. Treatment of symptomatic bullous keratopathy with poor visual prognosis using a modified Gundersen conjunctival flap and amniotic membrane. Ophthalmic Surg Las Imag. 2012;43:508-12.

  19. Ires RT, Tseng SC, Prabhasawat P, et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol. 1999;117:1291-7.

  20. Dos Santos Paris F, Domingues Gonçalves E, Silveira de Queiroz Campos M, Hideo Sato E, Dua HS, Pereira Gomes JA. Amniotic membrane transplantation versus anterior stromal puncture in bullous keratopathy: a comparative study. Braz J Ophthalmol. 2013; 97(8):980-4.

  21. Okumura N, Koizumi N, Ueno M. Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops. Br J Ophthalmol. 2011;95:1006-9.

  22. Okumura N, Koizumi N, Kay EP. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing . Invest Ophthalmol Vis Sci. 2013;54:2493-2502.

  23. Kinoshita S, Koizumi N, Ueno M. Injection of cultured cells with a ROCK inhibitor for bullous keratopathy. N Engl J Med . 2018;378: 995-1003.

  24. Parekh M, Ahmad S, Ruzza A. Human corneal endothelial cell cultivation from old donor corneas with forced attachment. Sci Rep. 2017;7:142.

  25. Khan MS, Basit I, Ishaq M, Shakoor T, Yakub A, Intisar R. Corneal Collagen Cross Linking (CXL) in treatment of Pseudophakic Bullous Keratopathy. Pak J Med Sci. 2016;32(4):965-8.

  26. Ritu A, Manudhane A, Saran R, Goyal J, Gupta D. Role of corneal collagen cross-linking in pseudophakic bullous keratopathy. Chicago, Illinois: American Academy of Ophthalmology Annual Meeting; 2012.

  27. Siu GD, Young AL, Jhanji V. Alternatives to corneal transplantation for the management of bullous keratopathy. Curr Op Ophthalmol. 2014;25(4):347-52.

  28. Reinhart JW, Musch DC, Jacobs SD, Lee WB, Kaufman SC, Shtein RM. Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty. Am Acad Ophthalmol. 2001;118(1):209-18.

  29. Mokey Castellanos MO. Rechazo y retrasplante corneal. Rev Cubana Oftalmol. 2007 [acceso: 25/11/2019];20(1). Disponible en: http://scielo.sld.cu/scielo.php?pid=S086421762007000100002&script=sci_arttext&tlng=en

  30. Mokey Castellanos MO. Resultados de la queratoplastia perforante en el edema corneal pseudoafáquico. Rev Univ Catol Guayaq. 1997;3920:86-80.

  31. Mokey Castellanos MO. Trasplante de córnea binocular, factores de importancia para la cirugía del segundo ojo. Rev Univ Catol Guayaquil. 1996;2(2):61-3.

  32. Abud TB, Di Zazzo, Kheirkhah A, Dana R. Systemic immunomodulatory strategies in high-risk corneal transplantation. J Ophthalmic Vis Res. 2017;12(1):81-92.




2020     |     www.medigraphic.com